Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000595

Drug Information
NamePF-217830
SynonymsPF-00217830; CID11697676; 7-[4-(4-naphthalen-1-ylpiperazin-1-yl)butoxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one; PF-217830
CompanyPfizer
IndicationSchizophrenia
[ICD9: 295   ICD10: F20]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C26H30N4O2/c31-24-12-10-21-11-13-25(28-26(21)27-24)32-19-4-3-1
4-29-15-17-30(18-16-29)23-9-5-7-20-6-1-2-8-22(20)23/h1-2,5-9,11,1
3H,3-4,10,12,14-19H2,(H,27,28,31)
InChIKeyQGNOXTFZOLDODX-UHFFFAOYSA-N
Canonical SMILESC1CC(=O)NC2=C1C=CC(=N2)OCCCCN3CCN(CC3)C4=CC=CC5=CC=CC=C54    
PubChem Compound IDCID 11697676.
PubChem Substance IDSID 16802186.
TargetD(3) dopamine receptorAntagonist[1]
Ref 1Pfizer. Product Development Pipeline. March 31 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543